AGP Picks
View all

Health Press Barbados
Provided by AGP

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 4, 2026

Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases
Aug. 4, 2026

Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases

Indeterminate GlobeNewswire
Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference
Aug. 4, 2026

Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Aug. 4, 2026

Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology

Indeterminate GlobeNewswire
NeurAxis Expands Payer Coverage with New Policies
Aug. 4, 2026

NeurAxis Expands Payer Coverage with New Policies

Indeterminate GlobeNewswire
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Aug. 4, 2026

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Indeterminate GlobeNewswire
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
Aug. 4, 2026

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire
ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models
Aug. 4, 2026

ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
Aug. 4, 2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Indeterminate GlobeNewswire
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
Aug. 4, 2026

Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.

Indeterminate GlobeNewswire
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Certara Reports Second Quarter 2026 Financial Results
Aug. 4, 2026

Certara Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
Aug. 4, 2026

Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases

Indeterminate GlobeNewswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
Aug. 4, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire
Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
Aug. 4, 2026

Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader

Indeterminate GlobeNewswire
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
Aug. 4, 2026

Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Aug. 4, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy
Aug. 4, 2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Press Barbados

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.